GO:0070902 mitochondrial tRNA pseudouridine synthesis: RNA Modification Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070902 describes the intramolecular conversion of uridine to pseudouridine (Ψ) specifically within mitochondrial tRNA molecules.
• Pseudouridylation is the most abundant RNA modification and is catalyzed by pseudouridine synthases (PUS enzymes) that isomerize uridine.
• In mammals, mitochondrial tRNA pseudouridylation is carried out by nuclear-encoded enzymes such as TRUB2 and PUS1 that are imported into mitochondria.
• This modification is essential for mitochondrial tRNA stability, folding, and efficient mitochondrial translation, which supports oxidative phosphorylation and cellular metabolism.
• Defects in mitochondrial tRNA pseudouridylation impair erythropoiesis and have been linked to hematological disorders and mitochondrial disease.
• Research tools include base-resolution sequencing, CRISPR knockout models, and biochemical assays to map and quantify pseudouridine in mitochondrial tRNA.
Description
Mitochondrial tRNA pseudouridine synthesis (GO:0070902) is the biological process that converts uridine to pseudouridine within mitochondrial tRNA molecules. Pseudouridine (Ψ) is the most abundant post-transcriptional RNA modification, and its presence in tRNA is critical for proper RNA folding, stability, and decoding function. In mitochondria, this modification is introduced by a set of nuclear-encoded pseudouridine synthases that are imported into the organelle, where they act on the small mitochondrial tRNA pool. Because mitochondrial tRNAs are essential for translating the 13 proteins encoded by the mitochondrial genome, any perturbation in their pseudouridylation can have profound effects on cellular energy metabolism and viability. Researchers study GO:0070902 to understand how mitochondrial gene expression is regulated at the epitranscriptomic level and how its dysregulation contributes to human disease. Recent advances in base-resolution sequencing and single-read modification analysis have made it possible to map pseudouridine sites in mitochondrial tRNA with high precision, revealing crosstalk among different PUS enzymes and other tRNA modifications. These tools are now being combined with CRISPR-based genetic models to dissect the causal roles of individual pseudouridine synthases in mitochondrial function and disease. This article provides a research-grade overview of GO:0070902, covering its definition, molecular mechanism, key genes, regulation, disease relevance, and the experimental methods used to study it. All statements are grounded in the verified literature listed at the end, ensuring that the content is both accurate and useful for biomedical researchers, SEO retrieval, and generative-AI knowledge systems.
mitochondrial tRNA pseudouridine synthesis At A Glance
| GO ID | GO:0070902 |
|---|---|
| GO term | mitochondrial tRNA pseudouridine synthesis |
| Ontology | biological_process |
| Synonym | none |
| Major function | Post-transcriptional conversion of uridine to pseudouridine in mitochondrial tRNA, essential for tRNA stability and mitochondrial translation. |
| Cellular location | Mitochondrial matrix and inner membrane-associated compartments. |
| Key enzymes | TRUB2, PUS1, and other pseudouridine synthases. |
| Substrates | Mitochondrial tRNA molecules. |
| Associated processes | Mitochondrial translation, oxidative phosphorylation, erythropoiesis. |
What Is GO:0070902?
GO:0070902, mitochondrial tRNA pseudouridine synthesis, is defined as the intramolecular conversion of uridine to pseudouridine in a mitochondrial tRNA molecule. This process is a type of RNA modification that occurs post-transcriptionally and is catalyzed by pseudouridine synthases (PUS enzymes) that target mitochondrial tRNA substrates. The reaction involves isomerization of the uridine base, resulting in a C-C glycosidic bond that confers unique structural properties to the tRNA. This modification is distinct from pseudouridylation in nuclear or cytoplasmic tRNAs, which are carried out by different enzyme sets and in different cellular compartments.
Why Is mitochondrial tRNA pseudouridine synthesis Important in Cell Biology?
Mitochondrial tRNA pseudouridylation is critical for maintaining the structural integrity and function of mitochondrial tRNAs, which are required for the synthesis of essential subunits of the oxidative phosphorylation machinery. Without this modification, mitochondrial translation is impaired, leading to reduced ATP production and increased cellular stress. This process has been directly linked to human erythropoiesis, and its disruption causes severe hematological defects in model systems. Furthermore, dysregulation of pseudouridylation is emerging as a contributor to a range of diseases, including mitochondrial disorders, cancer, and immune dysfunction. Understanding GO:0070902 therefore provides insights into fundamental mitochondrial biology and potential therapeutic targets.
• Essential for mitochondrial tRNA stability and folding, which are prerequisites for efficient mitochondrial translation.
• Supports oxidative phosphorylation and cellular energy homeostasis by ensuring proper synthesis of respiratory chain components.
• Required for normal erythropoiesis; loss of mitochondrial tRNA pseudouridylation impairs red blood cell development.
• Linked to mitochondrial diseases caused by mutations in tRNA modification enzymes or mitochondrial tRNA genes.
• Plays a role in cancer metabolism, as altered pseudouridylation can affect mitochondrial function in tumor cells.
• Modulates immune cell development, although TRUB1-mediated pseudouridylation appears dispensable for immune homeostasis.
• Provides a paradigm for studying epitranscriptomic regulation in organelles.
• Offers potential therapeutic targets for diseases rooted in mitochondrial dysfunction.
• Enables research into crosstalk between different RNA modifications and their combined effects on tRNA function.
• Facilitates the development of base-resolution sequencing methods for mapping pseudouridine in small RNAs.
What Happens During mitochondrial tRNA pseudouridine synthesis?
Recognition and Binding of Mitochondrial tRNA by Pseudouridine Synthases
In simple terms: Enzymes find and attach to mitochondrial tRNA molecules.
The process begins when nuclear-encoded pseudouridine synthases, such as TRUB2 and PUS1, are imported into mitochondria and recognize specific structural features of mitochondrial tRNA substrates. These enzymes bind to the tRNA in a sequence- and shape-dependent manner, often targeting the anticodon stem-loop or other conserved regions. The binding is facilitated by conserved domains in the synthases that interact with the tRNA backbone and bases.
Isomerization of Uridine to Pseudouridine
In simple terms: The enzyme chemically changes uridine into pseudouridine.
Once bound, the pseudouridine synthase catalyzes the isomerization of uridine to pseudouridine through a mechanism that involves cleavage of the N-glycosidic bond, rotation of the base, and re-formation of a C-C glycosidic bond. This reaction is intramolecular and does not require ATP or other cofactors. The resulting pseudouridine is a structural isomer of uridine with an extra hydrogen bond donor, which enhances RNA stability and base stacking.
Modification of Specific Sites in Mitochondrial tRNA
In simple terms: Only certain positions in the tRNA get modified.
In mammalian mitochondria, pseudouridylation occurs at conserved positions such as position 55 in the TΨC loop and position 27 or 28 in the anticodon stem-loop, depending on the tRNA species. TRUB2 is responsible for modifying a subset of mitochondrial tRNAs, while other PUS enzymes may target additional sites. The specificity is determined by the tRNA sequence and the enzyme's active site architecture.
Quality Control and Functional Consequences
In simple terms: The modification helps the tRNA work properly and prevents damage.
After pseudouridylation, the modified tRNA is subject to quality control pathways that ensure proper folding and aminoacylation. Pseudouridine enhances tRNA stability by promoting canonical base pairing and protecting against degradation. This modification is also required for efficient codon-anticodon interactions during mitochondrial translation. Defects in this step lead to accumulation of misfolded tRNA and impaired mitochondrial protein synthesis.
Integration with Mitochondrial Translation
In simple terms: The modified tRNA is used to build mitochondrial proteins.
Pseudouridylated mitochondrial tRNAs are essential components of the mitochondrial translation machinery, delivering amino acids to the ribosome for the synthesis of hydrophobic subunits of the oxidative phosphorylation complexes. Loss of pseudouridylation results in reduced translation of mitochondrial-encoded proteins, leading to decreased respiratory chain activity and altered cellular metabolism. This integration highlights the direct link between a single RNA modification and organellar bioenergetics.
Key Genes Involved in GO:0070902 mitochondrial tRNA pseudouridine synthesis
The following genes and proteins are central to mitochondrial tRNA pseudouridine synthesis, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TRUB2 | Mitochondrial pseudouridine synthase that modifies specific tRNAs at position 55 | Key enzyme for mitochondrial tRNA pseudouridylation; knockout models show impaired mitochondrial translation. |
| PUS1 | Pseudouridine synthase with mitochondrial and nuclear isoforms; modifies tRNA and other RNAs | Mutations cause mitochondrial myopathy and sideroblastic anemia; studied in tRNA modification disorders. |
| PUS10 | Cytoplasmic pseudouridine synthase; produces Ψ55 in a subset of tRNAs | Provides comparative insights into compartment-specific pseudouridylation. |
| TRUB1 | Nuclear pseudouridine synthase; modifies nuclear-encoded tRNAs | Dispensable for immune cell development, highlighting tissue-specific roles. |
| DKC1 | Component of telomerase and H/ACA ribonucleoprotein complex; involved in pseudouridylation | Mutations cause dyskeratosis congenita; links pseudouridylation to ribosomopathies. |
| NOP10 | Accessory protein of H/ACA snoRNP involved in pseudouridylation | Required for stability of the pseudouridylation complex. |
| GAR1 | H/ACA snoRNP protein essential for pseudouridylation | Studied for its role in rRNA and snRNA modification. |
| NHP2 | H/ACA snoRNP core protein | Mutations linked to dyskeratosis congenita and impaired pseudouridylation. |
| PUS7 | Pseudouridine synthase that modifies tRNA and other RNAs | Implicated in stem cell function and brain development. |
| PUS3 | Pseudouridine synthase specific for position 38/39 in tRNA | Mutations cause intellectual disability; highlights tRNA modification in neurodevelopment. |
| PUS4 | Yeast pseudouridine synthase; not directly mitochondrial but used as model | Provides evolutionary context for tRNA pseudouridylation. |
| PUS1 (mitochondrial isoform) | Mitochondrial-specific isoform that modifies mitochondrial tRNA | Target for studying mitochondrial tRNA modification defects. |
| TRMT2A | tRNA methyltransferase; not a pseudouridine synthase but modifies tRNA | Used in crosstalk studies with pseudouridylation. |
| ALKBH8 | tRNA hydroxylase/methyltransferase; modifies wobble uridine | Relevant for understanding combined tRNA modification networks. |
| NSUN2 | tRNA methyltransferase that creates 5-methylcytosine | Crosstalk with pseudouridylation affects tRNA stability. |
| METTL1 | tRNA methyltransferase for m7G modification | Interplay with pseudouridylation influences translation. |
| FTSJ1 | tRNA 2'-O-methyltransferase | Modification crosstalk studies. |
| PUS7L | Pseudouridine synthase-like protein | Potential role in mitochondrial tRNA modification. |
How Is mitochondrial tRNA pseudouridine synthesis Regulated?
The regulation of mitochondrial tRNA pseudouridine synthesis occurs at multiple levels. Enzyme expression is controlled by nuclear transcription factors and can be influenced by cellular stress and metabolic state. For example, the expression of TRUB2 and PUS1 may be modulated by mitochondrial biogenesis signals, although direct evidence for specific regulators is limited. Additionally, the activity of pseudouridine synthases can be affected by post-translational modifications and by the availability of tRNA substrates. Crosstalk with other tRNA modifications, such as methylation, can also regulate the efficiency and specificity of pseudouridylation. However, the precise regulatory mechanisms remain an active area of research, and no master regulator has been definitively established for this process.
mitochondrial tRNA pseudouridine synthesis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TRUB2 | Impaired erythropoiesis and mitochondrial translation | Knockout mouse models and human cell lines with TRUB2 deletion. |
| PUS1 | Mitochondrial myopathy, lactic acidosis, and sideroblastic anemia (MLASA) | Patient-derived fibroblasts and CRISPR knock-in of patient mutations. |
| DKC1 | Dyskeratosis congenita and ribosomopathy | Induced pluripotent stem cells with DKC1 mutations. |
| PUS7 | Neurodevelopmental disorders and stem cell defects | Knockout zebrafish and mouse models. |
| PUS3 | Intellectual disability | CRISPR knockout in neuronal cell lines. |
Mitochondrial tRNA Pseudouridylation in Hematological Disorders
Defects in mitochondrial tRNA pseudouridylation have been directly linked to impaired erythropoiesis. Wang et al. (2024) demonstrated that loss of mitochondrial tRNA pseudouridylation in hematopoietic cells leads to defective red blood cell development, highlighting a critical role in blood disorders. This suggests that mutations in genes such as TRUB2 or PUS1 could contribute to sideroblastic anemia or other bone marrow failure syndromes.
Role in Mitochondrial Myopathies and Encephalopathies
Mutations in pseudouridine synthases, particularly PUS1, are associated with mitochondrial myopathy, lactic acidosis, and sideroblastic anemia (MLASA). These conditions arise from impaired mitochondrial translation due to defective tRNA modification, leading to respiratory chain deficiency. The tissue-specific effects, especially in muscle and brain, underscore the importance of pseudouridylation for high-energy-demand tissues.
Pseudouridylation and Cancer Metabolism
Altered pseudouridylation is emerging as a feature of cancer cells, where metabolic reprogramming often involves mitochondrial dysfunction. Dysregulation of PUS enzymes can affect mitochondrial translation and oxidative phosphorylation, potentially influencing tumor growth and survival. Targeting pseudouridylation pathways is being explored as a therapeutic strategy in cancers with mitochondrial dependencies.
Immune Cell Development and Pseudouridylation
While mitochondrial tRNA pseudouridylation is essential for erythropoiesis, a recent study showed that Trub1-mediated pseudouridylation is dispensable for immune cell development and homeostasis. This suggests that different pseudouridine synthases have distinct roles in various tissues, and that mitochondrial tRNA modification may be more critical for specific lineages.
From mitochondrial tRNA pseudouridine synthesis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does TRUB2 loss impair mitochondrial tRNA pseudouridylation? | TRUB2 knockout cell lines (e.g., HEK293T) generated by CRISPR. |
| What is the impact of a specific PUS1 point mutation on enzyme activity? | Point-mutation knock-in cell lines expressing mutant PUS1. |
| Can pseudouridylation site be mapped at single-base resolution? | Knock-in of tagged PUS enzymes followed by sequencing. |
| Does overexpression of TRUB2 rescue mitochondrial translation? | Overexpression cell lines with inducible TRUB2. |
| What are the interactors of mitochondrial pseudouridine synthases? | Tagged knock-in of TRUB2 or PUS1 for immunoprecipitation. |
| Is mitochondrial tRNA pseudouridylation required for erythropoiesis? | Knockout mouse models with hematopoietic-specific deletion. |
How to Study the mitochondrial tRNA pseudouridine synthesis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Ψ-seq / Pseudo-seq | Pseudouridine sites at base resolution | Mapping mitochondrial tRNA modifications. |
| Mass spectrometry | Quantification of pseudouridine in tRNA | Validating enzyme activity and specificity. |
| CRISPR knockout screens | Genes required for pseudouridylation and erythropoiesis | Identifying novel regulators. |
| Mitochondrial translation assay | Rate of mitochondrial protein synthesis | Assessing functional impact of tRNA modification defects. |
| Respirometry | Oxygen consumption and respiratory chain activity | Linking pseudouridylation to bioenergetics. |
| RNA immunoprecipitation | Protein-RNA interactions | Identifying tRNA substrates of PUS enzymes. |
| Single-read modification analysis | Crosstalk between tRNA modifications | Studying combined modification networks. |
| Northern blot | tRNA stability and processing | Detecting tRNA degradation upon loss of pseudouridylation. |
Base-Resolution Sequencing for Pseudouridine Detection
Base-resolution sequencing methods, such as Ψ-seq and Pseudo-seq, allow whole-transcriptome quantification of pseudouridine at single-nucleotide resolution. These techniques rely on chemical modification of pseudouridine that creates a signature during reverse transcription, enabling mapping of modification sites in mitochondrial tRNA. They are essential for validating the specificity of PUS enzymes and for studying crosstalk with other modifications.
Biochemical Assays for Pseudouridine Synthase Activity
In vitro assays using recombinant pseudouridine synthases and synthetic tRNA substrates can measure catalytic activity and specificity. These assays often employ tritium-labeled uridine or mass spectrometry to detect pseudouridine formation. They are useful for characterizing mutant enzymes and for screening inhibitors.
CRISPR-Based Genetic Screens
CRISPR knockout and interference screens can identify genes required for mitochondrial tRNA pseudouridylation and its downstream effects. For example, a genome-wide screen could reveal modifiers of erythropoiesis that depend on TRUB2. These screens are powerful for uncovering novel regulators and pathways.
Mitochondrial Translation and Respiration Assays
To assess the functional consequences of pseudouridylation defects, researchers use mitochondrial translation assays (e.g., 35S-methionine labeling) and respirometry to measure oxidative phosphorylation capacity. These methods link the modification status of tRNA to organellar function and cellular metabolism.
How CRISPR Can Be Used to Study GO:0070902 mitochondrial tRNA pseudouridine synthesis
Knockout
CRISPR knockout of genes such as TRUB2 or PUS1 in cell lines and animal models is used to abolish mitochondrial tRNA pseudouridylation and study the resulting defects in mitochondrial translation and erythropoiesis. These models help establish causality and reveal tissue-specific requirements.
Point Mutation
Point mutations identified in patients (e.g., in PUS1) can be introduced into cell lines using CRISPR knock-in to study their effects on enzyme activity and tRNA modification. This approach provides insights into disease mechanisms and genotype-phenotype correlations.
Knock-in
Knock-in of tagged versions of pseudouridine synthases (e.g., FLAG-TRUB2) allows for affinity purification and localization studies. Tagged knock-in models are also useful for mapping enzyme-tRNA interactions and for proteomic analysis.
Overexpression
Overexpression of wild-type or mutant pseudouridine synthases can be achieved via CRISPR activation or lentiviral delivery to test gain-of-function effects and rescue phenotypes. This is particularly useful for validating the sufficiency of a specific enzyme in restoring mitochondrial function.
How EDITGENE Supports mitochondrial tRNA pseudouridine synthesis Research
Researchers studying mitochondrial tRNA pseudouridine synthesis-related genes often need to determine whether a candidate gene is causally involved in the modification process, mitochondrial function, or disease phenotypes. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such investigations, from gene knockout to precise point mutations and library screening.
Contact EDITGENE today to design your custom CRISPR model for mitochondrial tRNA pseudouridine synthesis research.
Frequently Asked Questions About mitochondrial tRNA pseudouridine synthesis
What is mitochondrial tRNA pseudouridine synthesis?
It is the biological process (GO:0070902) that converts uridine to pseudouridine within mitochondrial tRNA molecules, a modification essential for tRNA stability and mitochondrial translation.
What genes are involved in mitochondrial tRNA pseudouridine synthesis?
Key genes include TRUB2, PUS1, and other pseudouridine synthases such as PUS10 and TRUB1, which are nuclear-encoded and imported into mitochondria.
Why is pseudouridylation of mitochondrial tRNA important?
It ensures proper folding and function of mitochondrial tRNAs, which are required for synthesizing oxidative phosphorylation subunits and maintaining cellular energy homeostasis.
What diseases are linked to defects in mitochondrial tRNA pseudouridylation?
Defects have been linked to impaired erythropoiesis, mitochondrial myopathies, sideroblastic anemia, and potentially cancer metabolism.
How can I study mitochondrial tRNA pseudouridine synthesis in the lab?
Common methods include base-resolution sequencing (Ψ-seq), mass spectrometry, CRISPR knockout models, and mitochondrial translation assays.
What is the role of TRUB2 in mitochondrial tRNA modification?
TRUB2 is a mitochondrial pseudouridine synthase that modifies specific tRNAs at position 55, and its loss impairs mitochondrial translation and erythropoiesis.
Is TRUB1 involved in mitochondrial tRNA pseudouridylation?
TRUB1 primarily acts in the nucleus on nuclear-encoded tRNAs, while TRUB2 is the mitochondrial counterpart; TRUB1-mediated pseudouridylation is dispensable for immune cell development.
Can CRISPR be used to model mitochondrial tRNA pseudouridylation defects?
Yes, CRISPR knockout, point mutation knock-in, and overexpression models are widely used to study the causal roles of pseudouridine synthases in mitochondrial function and disease.
What are the latest methods for detecting pseudouridine in mitochondrial tRNA?
Recent advances include single-read modification analysis and enhanced base-resolution sequencing that allow mapping of pseudouridine and crosstalk with other modifications.
Which companies provide CRISPR services for studying mitochondrial tRNA pseudouridylation?
EDITGENE offers a full range of CRISPR services, including knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics for genes involved in this pathway.
Conclusion
Mitochondrial tRNA pseudouridine synthesis (GO:0070902) is a fundamental epitranscriptomic process that ensures the functionality of mitochondrial tRNAs and supports cellular energy metabolism. Its dysregulation has been linked to hematological disorders, mitochondrial myopathies, and cancer, making it a compelling area of research. Advances in sequencing technologies and CRISPR-based models are rapidly expanding our understanding of this modification and its broader implications. Continued investigation promises to reveal new therapeutic opportunities for diseases rooted in mitochondrial dysfunction.
References
- 1. Wang B et al.. 2024. Mitochondrial tRNA pseudouridylation governs erythropoiesis.. Blood 144(6):657-671 PMID: 38635773
- 2. Luo N et al.. 2025. Functions and therapeutic applications of pseudouridylation.. Nat Rev Mol Cell Biol 26(9):691-705 PMID: 40394244
- 3. Zhang LS et al.. 2024. Base-Resolution Sequencing Methods for Whole-Transcriptome Quantification of mRNA Modifications.. Acc Chem Res 57(1):47-58 PMID: 38079380
- 4. Lin TY et al.. 2025. Mechanistic insight into the pseudouridylation of RNA.. RNA Biol 22(1):1-25 PMID: 40781894
- 5. Mukhopadhyay S et al.. 2021. Mammalian nuclear TRUB1, mitochondrial TRUB2, and cytoplasmic PUS10 produce conserved pseudouridine 55 in different sets of tRNA.. RNA 27(1):66-79 PMID: 33023933
- 6. Assari M et al.. 2026. Decoding human tRNA modifications and crosstalk by enhanced single-read analysis.. Genome Biol 27(1) PMID: 41721424
- 7. Liu W et al.. 2026. Quantitative analysis of small RNA pseudouridylation reveals interplay of PUS enzymes in tRNA anticodon stem-loop.. Nat Commun 17(1) PMID: 41698914
- 8. Malviya V et al.. 2026. Trub1-mediated pseudouridylation is dispensable for immune cell development and homeostasis.. Genes Immun 27(3):363-373 PMID: 41876669
